Dec 05, 2019
Check and Point to Side Effects
Uveitis, Cornea/External Disease
1 Self-Assessment AMA PRA Category 1 Credits™
An 80-year-old woman who was referred to your eye clinic by her dermatologist presents with symptoms of progressive, bilateral blurred vision 2 weeks following her second infusion of nivolumab as monotherapy for metastatic BRAF-positive malignant melanoma.